Different studies have investigated the implications of these proteins in NAFLD and its progression to NASH in relation to inflammation and fibrosis [53,54], which is why it is well established that regulation of the TGFB pathway is related to liver pathology. Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.